Nancy Pecota's guest appearances

Nancy Pecota

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

 Patients with non-cystic fibrosis bronchiectasis (NCFBE), a progressive pulmonary disease, currently have no treatment options in the US. Nancy Pecota, CFO of Aradigm Corporation, discusses NCFBE and what Aradigm is doing to help these patients and possibly others who have an un-diagnosed condition . Their inhalable drug Linhaliq™ is currently on the fast track for FDA approval for NCFBE. Nancy discusses Aradigm’s progress to provide an effective treatment option  and prevent future infections in  these patients.   #bronchiectasis #NCFBE  #Linhaliq  #Aradigm  #pulmonarydisease Aradigm.com

Patients with non-cystic fibrosis bronchiectasis (NCFBE), a progressive pulmonary disease, currently have no treatment options in the US. Nancy Pecota, CFO of Aradigm Corporation, discusses NCFBE and what Aradigm is doing to help these patients and possibly others who have an un-diagnosed condition . Their inhalable drug Linhaliq™ is currently on the fast track for FDA approval for NCFBE. Nancy discusses Aradigm’s progress to provide an effective treatment option and prevent future infections in these patients. #bronchiectasis #NCFBE  #Linhaliq  #Aradigm  #pulmonarydisease <a href="http://aradigm.com" rel="noopener nofollow" target="_blank">Aradigm.com</a>

New Inhalation Drug Treats Pulmonary Disease with Nancy Pecota CFO Aradigm